| EXOSC5 |
EXOSC5, CML28, RRP46: Exosome complex exonuclease RRP46 |
EXOSC8 |
EXOSC8, OIP2, RRP43: Exosome complex exonuclease RRP43 |
6.877 |
Evidence |
O
|
| ESR1 |
ESR1, ESR, NR3A1: Estrogen receptor |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
6.86 |
Evidence |
|
| PSMD7 |
PSMD7, MOV34L: 26S proteasome non-ATPase regulatory subunit 7 |
PSMD6 |
PSMD6, KIAA0107, PFAAP4: 26S proteasome non-ATPase regulatory subunit 6 |
6.837 |
Evidence |
O
|
| PSMD14 |
PSMD14, POH1: 26S proteasome non-ATPase regulatory subunit 14 |
PSMD6 |
PSMD6, KIAA0107, PFAAP4: 26S proteasome non-ATPase regulatory subunit 6 |
6.837 |
Evidence |
O
|
| SQSTM1 |
SQSTM1: Uncharacterized protein SQSTM1 |
SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
6.825 |
Evidence |
|
| ACTG1 |
ACTB: Actin, cytoplasmic 1 |
CNN2 |
CNN2: Calponin-2 |
6.822 |
Evidence |
|
| CCNB1 |
Cyclin B1 |
CDC25C |
CDC25C: M-phase inducer phosphatase 3 |
6.822 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
6.822 |
Evidence |
O
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
6.822 |
Evidence |
|
| PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
SGK2 |
SGK2: Serine/threonine-protein kinase Sgk2 |
6.822 |
Evidence |
|
| PRKCG |
PRKCG, PKCG: Protein kinase C gamma type |
PARD3 |
IPI00154915 |
6.817 |
Evidence |
|
| SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
PCAF |
PCAF: Histone acetyltransferase PCAF |
6.817 |
Evidence |
|
| SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
LEF1 |
LEF1: Lymphoid enhancer-binding factor 1 |
6.817 |
Evidence |
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
6.807 |
Evidence |
|
| GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
KHDRBS1 |
KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate |
6.807 |
Evidence |
|
| MYBL2 |
MYBL2, BMYB: Myb-related protein B |
RBL1 |
RBL1: Retinoblastoma-like protein 1 |
6.807 |
Evidence |
|
| KHDRBS1 |
KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
6.807 |
Evidence |
|
| OPRD1 |
OPRD1, OPRD: Delta-type opioid receptor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
6.807 |
Evidence |
|
| CDK2 |
CDK2: Cell division protein kinase 2 |
RBL1 |
RBL1: Retinoblastoma-like protein 1 |
6.807 |
Evidence |
|
| TAF4 |
TAF4, TAF2C, TAF2C1, TAF4A, TAFII130, TAFII135: Transcription initiation factor |
TAF11 |
TAF11, TAF2I, PRO2134: Transcription initiation factor TFIID subunit 11 |
6.782 |
Evidence |
|
| NID1 |
NID1, NID: Nidogen-1 precursor |
FBLN2 |
FBLN2: Fibulin-2 precursor |
6.782 |
Evidence |
|
| TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
SMAD4 |
SMAD4, DPC4, MADH4: Mothers against decapentaplegic homolog 4 |
6.782 |
Evidence |
|
| IARS |
IARS: Isoleucyl-tRNA synthetase, cytoplasmic |
EPRS |
EPRS, GLNS, PARS, QARS, QPRS: Bifunctional aminoacyl-tRNA synthetase [Includes: |
6.77 |
Evidence |
O
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
6.73 |
Evidence |
O
|
| PEX7 |
PEX7, PTS2R: Peroxisomal targeting signal 2 receptor |
PEX13 |
PEX13: Peroxisomal membrane protein PEX13 |
6.71 |
Evidence |
O
|
-